XW143C8 Transfusion of Omidubicel into Central Vein, Percutaneous Approach, New Technology Group 8X New TechnologyW Anatomical Regions1 Transfusion4 Central Vein3 PercutaneousC Omidubicel8 New Technology Group 8added FY2023.
XW14325 Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach, New Technology Group 5XW1437A Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10XW143B8 Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8XW143E7 Transfusion of Hyperimmune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7XW143F8 Transfusion of Etuvetidigene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8XW143G8 Transfusion of Atidarsagene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8XW143H9 Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9XW143J8 Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8XW143SB Transfusion of Mozafancogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 11XW143YB Transfusion of Nonautologous (Human) Fibrinogen Concentrate, Shelf-stable into Central Vein, Percutaneous Approach, New Technology Group 11